Inorganic nanovehicle targets tumor in an orthotopic breast cancer model

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Choi, Goeun ^a   Kwon, Oh Joon ^b   Oh, Yeonji ^a   Yun, Chae Ok ^b   Choy, Jin Ho ^a  

^a Ewha Womans University   (South Korea)

^b Hanyang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM SILICATE; ANTINEOPLASTIC ANTIMETABOLITE; DRUG CARRIER; LIPOCORTIN 5; MAGNESIUM HYDROXIDE; METHOTREXATE; PROPIDIUM IODIDE;

ANIMAL; APOPTOSIS; ARTICLE; BREAST TUMOR; CANCER TRANSPLANTATION; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; DRUG FORMULATION; FEMALE; HALF LIFE TIME; HUMAN; LIVER; MOUSE; PARTICLE SIZE; PATHOLOGY; TUMOR CELL LINE; TUMOR VOLUME; UDDER; XENOGRAFT;

ALUMINUM SILICATES; ANIMALS; ANNEXIN A5; ANTIMETABOLITES, ANTINEOPLASTIC; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG CARRIERS; DRUG COMPOUNDING; FEMALE; HALF-LIFE; HETEROGRAFTS; HUMANS; LIVER; MAGNESIUM HYDROXIDE; MAMMARY GLANDS, ANIMAL; METHOTREXATE; MICE; NEOPLASM TRANSPLANTATION; PARTICLE SIZE; PROPIDIUM; TUMOR BURDEN;

EID: 84898866410     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04430     Document Type: Article

References (40)

1. y (m 5 1 and 2). Science 280, 1589-1592 (1998).
2. Xu, Z. P. et al. Stable suspension of layered double hydroxide nanoparticles in aqueous solution. J. Am. Chem. Soc. 128, 36-37 (2006).
3. Xu, Z. P. et al. Subcellular compartment targeting of layered double hydroxide nanoparticles. J. Control. Release 130, 86-94 (2008).
4. Wong, Y. Y. et al. Efficient delivery of siRNA to cortical neurons using layered double hydroxide nanoparticles. Biomaterials 31, 8770-8779 (2010).
5. Bao, H. F. et al. Synthesis of well-dispersed layered double hydroxide core@ ordered mesoporous silica shell nanostructure (LDH@mSiO2) and its application in drug delivery. Nanoscale 3, 4069-4073 (2011).
6. Yang, J. H. et al. New inorganic-based drug delivery system of indole-3-acetic acid-layered metal hydroxide nanohybrids with controlled release rate. Chem. Mater. 19, 2679-2685 (2007).
7. Ogawa, M. & Asai, S. Hydrothermal synthesis of layered double hydroxidedeoxycholate intercalation compounds. Chem. Mater. 12, 3253-3255 (2000).
8. Choy, J. H., Kwak, S. Y., Jeong, Y. J. & Park, J. S. Inorganic layered double hydroxide as a non-viral vectors. Angew. Chem. Int. Ed. 39, 4042-4045 (2000).
9. 2+ from seawater on a layered silicate. Angew. Chem. Int. Ed. 123, 680-682 (2011).
10. Maneeratana, V. et al. Fractal inorganic-organic interfaces in hybrid membranes for efficient proton transport. Adv. Funct. Mater. 23, 2872-2880 (2013).
11. Marquez, A. G. et al. Green scalable aerosol synthesis of porous metal-organic frameworks. Chem. Commun. 49, 3848-3850 (2013).
12. Chung, I. W. et al. Evidence of two-dimensional superconductivity in the single crystalline nanohybrid of organic-bismuth cuprate. J. Phys. Chem. B 110, 16197-16200 (2006).
13. Paek, S. M. et al. Exfoliation and reassembling route to mesoporous titania nanohybrids. Chem. Mater. 18, 1134-1140 (2006).
14. Oh, J. M., Choi, S. J., Kim, S. T. & Choy, J. H. Cellular uptake mechanism of an inorganic nanovehicle and its drug conjugates: enhanced efficacy due to clathrinmediated endocytosis. Bioconjugate Chem. 17, 1411-1417 (2006).
15. Khan, A. I., Lei, L., Norquist, A. J. & O'Hare, D. Intercalation and controlled release of pharmaceutically active compounds from a layered double hydroxide. Chem. Commun. 2342-2343 (2001).
16. Choi, G. et al. Inorganic-polymer nanohybrid carrier for delivery of a poorlysoluble drug, ursodeoxycholic acid. Int. J. Pharm. 402, 117-122 (2010).
17. Wang, Q. & O'Hare, D. Recent advances in the synthesis and application of layered double hydroxide (LDH) nanosheets. Chem. Rev. 112, 4124-4155 (2012).
18. Li, S. D. et al. Cellular uptake and gene delivery using layered double hydroxide nanoparticles. J. Mater. Chem. B 1, 61-68 (2013).
19. Gao, X. et al. Intercalation and controlled release properties of vitamin C intercalated layered double hydroxide. J. Solid State Chem. 203, 174-180 (2013).
20. Oh, J. M., Choi, S. J., Lee, G. E., Kim, J. E. & Choy, J. H. Inorganic metal hydroxide nanoparticles for targeted cellular uptake through clathrin-mediated endocytosis. Chem. Asian J. 4, 67-73 (2009).
21. Hussein, M. Z., Zainal, Z., Yahaya, A. H. & Foo, D. W. V. Controlled release of a plant growth regulator, α-naphthaleneacetate from the lamella of Zn-Al-layered double hydroxide nanocomposite. J. Control. Release 82, 417-427 (2002).
22. Choy, J. H., Oh, J. M., Park, M., Sohn, K.M. & Kim, J. W. Inorganic-biomolecular hybrid nanomaterials as a genetic molecular code system. Adv. Mater. 16, 1181-1184 (2004).
23. Kim, M. H., Park, D. H., Yang, J. H., Choy, Y. B. & Choy, J. H. Drug-inorganicpolymer nanohybrid for transdermal delivery. Int. J. Pharm. 444, 120-127 (2013).
24. Choy, J. H., Kwak, S. Y., Park, J. S., Jeong, Y. J. & Portier, J. Intercalative nanohybrids of nucleoside monophosphates and DNA in layered metal hydroxide. J. Am. Chem. Soc. 121, 1399-1400 (1999).
25. Kwak, S. Y., Waltraud, M. K., Matthew, A. W. & Choy, J. H. Inorganic delivery vector for intravenous injection. Biomaterials 25, 5995-6001 (2004).
26. Choi, S. J., Oh, J.M. & Choy, J. H. Human-related application and nanotoxicology of inorganic particles: complementary aspects. J. Mater. Chem. 18, 615-620 (2008).
27. Yokoyama, M. et al. Toxicity and antitumor activity against solid Ttumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res. 51, 3229-3236 (1991).
28. Parnham, M. J. & Wetzig, H. Toxicity screening of liposomes. Chem Phys Lipids. 64, 263-274 (1993).
29. Oh, J. M. et al. Efficient delivery of anticancer drug MTX through MTX-LDH nanohybrid system. J. Phys. Chem. Solids 67, 1024-1027 (2006).
30. Choy, J. H. et al. Layered double hydroxide as an efficient drug reservoir for folate derivatives. Biomaterials 25, 3059-3064 (2004).
31. Choi, S. J. & Choy, J. H. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity. Nanomedicine 6, 803-814 (2011).
32. Gilman, A. G., Goodman, L. S. & Gilman, A. [Chemotherapy of neoplastic diseases] [Brunton, L. L. (ed.)] [1315-1402] (Macmillan, New York, 2006).
33. Heijden, J. W., Dijkmans, B. A. C., Scheper, R. J. & Jansen, G. Drug Insight: resistance to methotrexate and other disease-modifying antirheumatic drugsfrom bench to bedside. Nat. Clin. Pract. Rheum. 3, 26-34 (2007).
34. McGuire, J. J. Anticancer antifolates: Current status and future directions. Curr. Pharm. Des. 9, 2593-2613 (2003).
35. Kim, J. Y., Choi, S. J., Oh, J.M., Park, T. & Choy, J. H. Anticancer drug-inorganic nanohybrid and its cellular interaction. J. Nanosci. Nanotechnol. 7, 3700-3705 (2007).
36. Torchilin, V. P. Targeted Pharmaceutical Nanocarriers for Cancer Therapy and Imaging. The AAPS Journal 9, E128-E147 (2007).
37. Maeda, H. SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 46, 169-185 (2001).
38. Maeda, H., Sawa, T. & Konno, T. Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J. Control. Release 74, 47-61 (2001).
39. Kloprogge, J. T. & Frost, R. L. Fourier Transform Infrared and Raman Spectroscopic Study of the Local Structure of Mg-, Ni-, and Co-Hydrotalcites. J. Solid State Chem. 146, 506-515 (1999).
40. Mancini, R., Marucci, L., Benedetti, A., Jezequel, A. M. & Orlandi, F. Immunohistochemical analysis of S-phase cells in normal human and rat liver by PC10 monoclonal antibody. Liver 14, 57-64 (1994).